Polymyalgia rheumatica: strategies for efficient practice and quality assurance

Michael Schirmer; Christian Dejaco; Bhaskar Dasgupta; Eric L. Matteson

doi:10.1007/s00296-015-3297-y

Polymyalgia rheumatica: strategies for efficient practice and quality assurance

Michael Schirmer, Christian Dejaco, Bhaskar Dasgupta, Eric L. Matteson

Research output: Contribution to journal › Review article › peer-review

7 Scopus citations

Abstract

Polymyalgia rheumatica (PMR) is the most common inflammatory rheumatic disease in persons over the age of 50 years. There are many diseases which mimic PMR, for which reason a careful diagnostic approach is required. While it is thought to be exquisitely responsive to glucocorticosteroid therapy, many patients respond incompletely and/or develop serious side effects over the protracted disease course. Improved methods for classification and disease assessment together with standardized treatment approaches and outcome assessments can serve to improve the care of patients with this disease.

Original language	English (US)
Pages (from-to)	1781-1789
Number of pages	9
Journal	Rheumatology International
Volume	35
Issue number	11
DOIs	https://doi.org/10.1007/s00296-015-3297-y
State	Published - Nov 1 2015

Keywords

Classification criteria
Diagnosis
Outcome
Polymyalgia rheumatica
Quality measures
Treatment

ASJC Scopus subject areas

Immunology and Allergy
Rheumatology
Immunology

Access to Document

10.1007/s00296-015-3297-y

Cite this

@article{4864ab1c345c4f5d835f90e4b6aa9d40,

title = "Polymyalgia rheumatica: strategies for efficient practice and quality assurance",

abstract = "Polymyalgia rheumatica (PMR) is the most common inflammatory rheumatic disease in persons over the age of 50 years. There are many diseases which mimic PMR, for which reason a careful diagnostic approach is required. While it is thought to be exquisitely responsive to glucocorticosteroid therapy, many patients respond incompletely and/or develop serious side effects over the protracted disease course. Improved methods for classification and disease assessment together with standardized treatment approaches and outcome assessments can serve to improve the care of patients with this disease.",

keywords = "Classification criteria, Diagnosis, Outcome, Polymyalgia rheumatica, Quality measures, Treatment",

author = "Michael Schirmer and Christian Dejaco and Bhaskar Dasgupta and Matteson, {Eric L.}",

note = "Publisher Copyright: {\textcopyright} 2015, Springer-Verlag Berlin Heidelberg.",

year = "2015",

month = nov,

day = "1",

doi = "10.1007/s00296-015-3297-y",

language = "English (US)",

volume = "35",

pages = "1781--1789",

journal = "Rheumatology International",

issn = "0172-8172",

publisher = "Springer Verlag",

number = "11",

}

TY - JOUR

T1 - Polymyalgia rheumatica

T2 - strategies for efficient practice and quality assurance

AU - Schirmer, Michael

AU - Dejaco, Christian

AU - Dasgupta, Bhaskar

AU - Matteson, Eric L.

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Polymyalgia rheumatica (PMR) is the most common inflammatory rheumatic disease in persons over the age of 50 years. There are many diseases which mimic PMR, for which reason a careful diagnostic approach is required. While it is thought to be exquisitely responsive to glucocorticosteroid therapy, many patients respond incompletely and/or develop serious side effects over the protracted disease course. Improved methods for classification and disease assessment together with standardized treatment approaches and outcome assessments can serve to improve the care of patients with this disease.

AB - Polymyalgia rheumatica (PMR) is the most common inflammatory rheumatic disease in persons over the age of 50 years. There are many diseases which mimic PMR, for which reason a careful diagnostic approach is required. While it is thought to be exquisitely responsive to glucocorticosteroid therapy, many patients respond incompletely and/or develop serious side effects over the protracted disease course. Improved methods for classification and disease assessment together with standardized treatment approaches and outcome assessments can serve to improve the care of patients with this disease.

KW - Classification criteria

KW - Diagnosis

KW - Outcome

KW - Polymyalgia rheumatica

KW - Quality measures

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84945474100&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945474100&partnerID=8YFLogxK

U2 - 10.1007/s00296-015-3297-y

DO - 10.1007/s00296-015-3297-y

M3 - Review article

C2 - 26032754

AN - SCOPUS:84945474100

SN - 0172-8172

VL - 35

SP - 1781

EP - 1789

JO - Rheumatology International

JF - Rheumatology International

IS - 11

ER -

Polymyalgia rheumatica: strategies for efficient practice and quality assurance

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this